newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026

PRINCETON, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers,